Abstract:Hepatitis C virus (HCV) only infects humans and chimpanzees, while GB virus B (GBV-B), another hepatotropic hepacivirus, infects small New World primates (tamarins and marmosets). In an effort to develop an immunocompetent small primate model for HCV infection to study HCV pathogenesis and vaccine approaches, we investigated the HCV life cycle step(s) that may be restricted in small primate hepatocytes. First, we found that replication-competent, genome-length chimeric HCV RNAs encoding GBV-B structural proteins in place of equivalent HCV sequences designed to allow entry into simian hepatocytes failed to induce viremia in tamarins following intrahepatic inoculation, nor did they lead to progeny virus in permissive, transfected human Huh7.5 hepatoma cells upon serial passage. This likely reflected the disruption of interactions between distantly related structural and nonstructural proteins that are essential for virion production, whereas such cross talk could be restored in similarly designed HCV intergenotypic recombinants via adaptive mutations in NS3 protease or helicase domains. Next, HCV entry into small primate hepatocytes was examined directly using HCV-pseudotyped retroviral particles (HCV-pp). HCV-pp efficiently infected tamarin hepatic cell lines and primary marmoset hepatocyte cultures through the use of the simian CD81 ortholog as a coreceptor, indicating that HCV entry is not restricted in small New World primate hepatocytes. Furthermore, we observed genomic replication and modest virus secretion following infection of primary marmoset hepatocyte cultures with a highly cell culture-adapted HCV strain. Thus, HCV can successfully complete its life cycle in primary simian hepatocytes, suggesting the possibility of adapting some HCV strains to small primate hosts. Importance: Hepatitis C virus (HCV) is an important human pathogen that infects over 150 million individuals worldwide and leads to chronic liver disease. The lack of a small animal model for this infection impedes the development of a preventive vaccine and pathogenesis studies. In seeking to establish a small primate model for HCV, we first attempted to generate recombinants between HCV and GB virus B (GBV-B), a hepacivirus that infects small New World primates (tamarins and marmosets). This approach revealed that the genetic distance between these hepaciviruses likely prevented virus morphogenesis. We next showed that HCV pseudoparticles were able to infect tamarin or marmoset hepatocytes efficiently, demonstrating that there was no restriction in HCV entry into these simian cells. Furthermore, we found that a highly cell culture-adapted HCV strain was able to achieve a complete viral cycle in primary marmoset hepatocyte cultures, providing a promising basis for further HCV adaptation to small primate hosts.

Dynamics of Acute Hepatitis B Virus Infection in Chimpanzees.

Dynamic Analysis of HBV Infection Model with Simulations for Anti-HBV Infection Therapy

Animal Models for the Study of Hepatitis B Virus Infection.

Modeling Hepatitis B Virus Infection, Immunopathology and Therapy in Mice

Progress of Infection and Replication Systems of Hepatitis B Virus

Study of Dynamics of Dimensionless Basic Virus Infection Model and Prediction for Long Term Therapy Efficacy

Modeling and Application of Discrete System for HBV Infection

Discrete virus infection model of hepatitis B virus

Modeling the Effects of Covalently Closed Circular DNA and Dendritic Cells in Chronic HBV Infection.

Understanding Hepatitis B Virus Dynamics and the Antiviral Effect of Interferon Alpha Treatment in Humanized Chimeric Mice

In vivo adaptation of hepatitis C virus in chimpanzees for efficient virus production and evasion of apoptosis

Antibody Responses during Hepatitis B Viral Infection

Dynamics Analysis and Numerical Simulation of An Amended HBV Infection Model

Long-term hepatitis B virus infection of rhesus macaques requires suppression of host immunity

Intracellular Dynamics of Hepatitis B Virus Infection: A Mathematical Model and Global Sensitivity Analysis of Its Parameters

Multi-point Infection Dynamics of Hepatitis B in the Presence of Sub-Viral Particles

Global Analysis of A Viral Infection Model with Application to Hbv Infection

Mathematical Models of Early Hepatitis B Virus Dynamics in Humanized Mice

Dynamical analysis of a general delayed HBV infection model with capsids and adaptive immune response in presence of exposed infected hepatocytes

Determinants Involved in Hepatitis C Virus and GB Virus B Primate Host Restriction

Research on Viral Dynamic Models of Hepatitis B Virus Infection